IND clearance secured for Starlight Therapeutics and Myosin Therapeutics.

Pharma leaders Jazz Pharmaceuticals and Merck continue expanding into GBM through new investments and acquisitions.

Plus Therapeutics’ REYOBIQ shows a doubling of survival in recurrent GBM.

Denovo Biopharma’s DB102 advances into Phase III trials.

Starlight Therapeutics receives accelerated approval for its AI-enabled STAR-001 program.

Speakers

Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 7th Glioblastoma Drug Development Summit.

Do-Hyun Nam, speaking at 7th Glioblastoma Drug Development Summit

Do-Hyun Nam

Founder & Chief executive Officer
Aimed Bio Inc.

Mykola Zdioruk, speaking at the 7th Glioblastoma Drug Development Summit

Mykola Zdioruk

Senior Scientist
AstraZeneca

Kirk Tanner

Senior Vice President Clinical Development
Autem Therapeutics

John Higgins, speaking at the 7th Glioblastoma Drug Development Summit

John Higgins

Managing Director
Brain Tumor Investment Fund

Francesca Barone, speaking at 7th Glioblastoma Drug Development Summit

Francesca Barone

Chief Scientific Officer
Candel Therapeutics

Saskia Biskup, speaking at the 7th Glioblastoma Drug Development Summit

Saskia Biskup

Managing Director
CeGaT GmbH

Michael Boice, PhD

Senior Director, Scientific Engagement and Key Accounts
Certis Oncology Solution

Sandra Silberman, speaking at the 7th Glioblastoma Drug Development Summit

Sandra Silberman

CMO
CNS Pharmaceuticals

Liisi Laaniste, speaking at the 7th Glioblastoma Drug Development Summit

Liisi Laaniste

Chief Scientific Officer and Co-Founder
CoSyne Therapeutics

Ulrike Gerdermann, speaking at the 7th Glioblastoma Drug Development Summit

Ulrike Gerdemann

Principal Investigator & Physician Scientist
Dana-Farber Cancer Institute

Kimberly Lindstrom, speaking at the 7th Glioblastoma Drug Development Summit

Kimberly Lindstrom

Senior Vice President - Regulatory Science & Gcp Quality
Day One Biopharmaceuticals, Inc.

Sam Blackman, speaking at the 7th Glioblastoma Drug Development Summit

Sam Blackman

EIR
Google Ventures

Zohreh Amoozgar, speaking at the 7th Glioblastoma Drug Development Summit

Zohreh Amoozgar

Visiting Scientist
Harvard Medical School

Jianping Huang, speaking at the 7th Glioblastoma Drug Development Summit

Jianping Huang

CEO
Immunogenik

Aaron Edwards, speaking at 7th Glioblastoma Drug Development Summit

Aaron Edwards

Co-Founder & Chief Executive Officer
KiraGen Bio

Victoria Llado Canellas, speaking at the 7th Glioblastoma Drug Development Summit

Victoria Llado Canellas

Chief Strategy Officer
Laminar Pharma Inc

Panna Sharma, speaking at the 7th Glioblastoma Drug Development Summit

Panna Sharma

Chief Executive Officer, President & Board Member
Lantern Pharma

Fahar Merchant, speaking at the 7th Glioblastoma Drug Development Summit

Fahar Merchant

President & Chief Executive Officer
Medicenna Therapeutics

Carla bauer, speaking at 7th Glioblastoma Drug Development Summit

Carla Bauer

Director, Search & Evaluation, Business Development & Licensing
Merck & Co

Jason Binder, speaking at the 7th Glioblastoma Drug Development Summit

Jason Binder

Head of Patient Experience
Pathos AI

Sandeep Kunwar

Founder & Chief Executive Officer
Precision NeuroMed

Jonathan Pritz, speaking at the 7th Glioblastoma Drug Development Summit

Jonathan Pritz

Investment Director
RA Capital Management

Rashida Karmali

Daniel yokell, speaking at 7th Glioblastoma Drug Development Summit

Daniel Yokell

Vice President, Theranostic NeuroOncology
Telix Pharmaceuticals

David Tran, speaking at 7th Glioblastoma Drug Development Summit

David Tran

Chief, Associate Professor & Co-Director - Neuro-Oncology, Neurological Surgery & Neurology
University of Southern California

David Anderson, speaking at 7th Glioblastoma Drug Development Summit

David Anderson

Chief Scientific Officer
VBI Vaccines & HDT Bio

Erik Fossel

CEO
Viska Bio

Yash Thukral, speaking at the 7th Glioblastoma Drug Development Summit

Yash Thukral

Founding Partner
White Lion Capital LLC

Ranjit Bindra, speaking at the 7th Glioblastoma Drug Development Summit

Ranjit bindra

professor
Yale Univerisity

7th Glioblastoma Drug Development Summit - Conference Image

Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

View Presentations & Speakers

7th Glioblastoma Drug Development Summit - Conference Image

Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Explore Sponsorship Options

7th Glioblastoma Drug Development Summit - Conference Image

Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.